Serious cutaneous adverse drug reactions

41st Annual Meeting of Representatives of National Pharmacovigilance Centres

Lugar: Ginebra; Año: 2018;

Registries: Methodological challenges and Practical considerations

Fifth Symposium of International Society of Pharmacovigilance Latin-American chapter

Lugar: Sao Paulo; Año: 2018;

Non-insulin blood glucose lowering agents and Cardiovascular Outcomes in Type 2 Diabetes Mellitus

Fourth Symposium ISoP Latin-American chapter

Lugar: México; Año: 2017;

Pharmacovigilance in the time of zika

third Symposium Latin-American chapter

Lugar: Bogota; Año: 2016;

Farmacovigilancia en la Universidad Nacional de Córdoba, Argentina

Third Symposium of ISoP Latin-American chapter

Lugar: Bogota; Año: 2016;

Clinical assessment of signals

3rd ISoP-UMC Training Course

Lugar: Lima; Año: 2016;

How to learn Pharmacovigilance? Experience of the Universidad Nacional de Córdoba

2nd International Society of Pharmacovigilance Latin-American chapter

Lugar: Sao Paulo; Año: 2015;

Pharmacogenetics: understanding and preventing adverse drug reactions

2nd Symposium of ISoP Latin-American chapter

Lugar: Sao Paulo; Año: 2015;

Enseñanza de Farmacovigilancia en la Universidad Nacional de Córdoba

1st Symposium Latin-American chapter

Lugar: Buenos Aires; Año: 2014;

Publicación de casos y de series de casos

1st Symposium ISoP Latin-American chapter

Lugar: Buenos Aires; Año: 2014;

Isotretinoin in Argentina: embryopathy's known risks, unknown/disregarded intensive pharmacovigilance plans

37th Annual Meeting of the WHO Programme for International Drug Monitoring

Lugar: Tianjin; Año: 2014;

Individual Case Reports? (ICRs) Causality Assessment in Elderly: Why Not to Try the Inversion of Proof?

12th ISoP Annual Meeting

Lugar: Cancun; Año: 2012;

Impact of the first of CONSORT?s ten recommendations for reporting adverse effects in published clinical trials

12th ISoP Annual Meeting

Lugar: Cancun; Año: 2012;

Number of drugs usually taken by hospital inpatients before admission and Adverse Drug Reactions (ADRs) identified as cause of hospitalization

12th ISoP Annual Meeting

Lugar: Cancun; Año: 2012;

Electronic prescription as a tool for preventing medication errors, and potential use in continued education in a teaching Hospital.

12th ISoP Annual Meeting

Lugar: Cancun; Año: 2012;

Neglected populations, neglected diseases, neglected pharmacovigilance: a review of publications on Chagas pharmacovigilance

12th ISoP Annual Meeting

Lugar: Cancun; Año: 2012;

Different clinical manifestation of hypersensitivity to acetylsalicilic acid and Non-Steroidal Antiinflammatory drugs (NSAIDs): four case-reports as example of different subpopulations

12th ISoP Annual Meeting

Lugar: Cancun; Año: 2012;

Like DRESS syndrome in a 65 yr-old woman treated with losartan, esomeprazole and levothyroxine: case report

12th ISoP Annual Meeting

Lugar: Cancun; Año: 2012;

Causality assessment in individual case

ISoP Training course Reporting, Causality Assessmente¿, Risk

Lugar: Minsk; Año: 2011;

Pharmacogenetic approach in understanding and preventing Adverse Drug Reactions

ISoP Training course Minsk, Belarus- 26 & 27 May 2011

Lugar: Minsk; Año: 2011;

Preventability of Adverse Drug Reactions (ADRs) Leading to Hospital Admissions

11th ISoP Annual Meeting

Lugar: Estambul; Año: 2011;

Hospital Admissions Caused by Suspected Adverse Drug Reactions (ADRs) in a Hospital Clinical Medicine Unit in Córdoba, Argentina

11th ISoP Annual Meeting

Lugar: Estambul; Año: 2011;

Diagnosing and assessing Allergic Drug Reactions: case evaluation of maculopapular exanthaema with a antiretroviral three-drug treatment plus levofloxacine

10th ISoP Annual Meeting

Lugar: Accra; Año: 2010;

Anti-TNF paradoxical reactions: generalized papulopustular exanthaema with etanercept and palmoplantar pustular eruption with adalimumab in a woman with Psoriatic Arthritis

10th ISoP Annual Meeting

Lugar: Accra; Año: 2010;

Positive challenge tests with placebo in patients with history of reactions to multiple drugs

10th ISoP Annual Meeting

Lugar: Accra; Año: 2010;

Case report: Fatal bradycardia with nebivolol in a patient taking amiodarone for Chronic Atrial Fibrillation (AF)

33rd Annual Meeting of the WHO Programme for International Drug Monitoring

Lugar: Accra; Año: 2010;